Caption Management’s AbbVie ABBV Stock Holding History

Caption Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.7M	Buy	+100,000	New	+$22.2M	0.13%	171
2025 Q4	–	Sell	-198,000	Closed	-$45.8M	–	1519
2025 Q3	$45.8M	Buy	+198,000	New	+$40.3M	0.36%	51
2025 Q2	–	Sell	-59,000	Closed	-$12.4M	–	1384
2025 Q1	$12.4M	Buy	+59,000	New	+$11.5M	0.12%	155
2024 Q1	–	Sell	-55,000	Closed	-$8.52M	–	1128
2023 Q4	$8.52M	Hold	55,000	–	–	0.11%	206
2023 Q3	$8.2M	Hold	55,000	–	–	0.13%	194
2023 Q2	$7.41M	Buy	55,000 +25,000	+83%	+$3.67M	0.13%	202
2023 Q1	$4.78M	Buy	+30,000	New	+$4.59M	0.09%	242
2019 Q2	–	Sell	-65,000	Closed	-$5.24M	–	642
2019 Q1	$5.24M	Buy	+65,000	New	+$5.32M	0.29%	103

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caption Management's ABBV Position: Q1 2026 in Review

Caption Management increased its AbbVie (ABBV) stake by 109% in Q1 2026, buying an estimated $3.9M and bringing the position to 33,700 shares worth $7.33M. The position accounts for 0.04% of the portfolio, ranked #417.

Caption Management first reported a position in ABBV in Q1 2019 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2021. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Caption Management held 33,700 shares of AbbVie worth $7.33M as of Q1 2026.
Caption Management bought 17,600 AbbVie shares in Q1 2026, an estimated $3.9M.
AbbVie made up 0.04% of Caption Management's portfolio in Q1 2026, its #417 holding.
Caption Management first reported a position in AbbVie in Q1 2019 and has held it in 8 quarters since.
Caption Management's AbbVie position peaked at $10.2M in Q4 2021.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.